Dexamethasone Treatment after the First Week of Life for Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review

@article{Doyle2010DexamethasoneTA,
  title={Dexamethasone Treatment after the First Week of Life for Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review},
  author={L. Doyle and R. Ehrenkranz and H. Halliday},
  journal={Neonatology},
  year={2010},
  volume={98},
  pages={289 - 296}
}
  • L. Doyle, R. Ehrenkranz, H. Halliday
  • Published 2010
  • Medicine
  • Neonatology
  • Background: Dexamethasone has powerful anti-inflammatory effects and has been used to treat established bronchopulmonary dysplasia (BPD), but it is uncertain whether the benefits outweigh the risks of treatment. Objectives: To determine the effect of late (>7 days) postnatal dexamethasone treatment compared with control (placebo or nothing) to prevent or treat BPD in the preterm infant. Methods: Randomised controlled trials (RCTs) of late postnatal dexamethasone therapy to treat or prevent BPD… CONTINUE READING
    Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.
    • 166
    • PDF
    Epinephrine for bronchiolitis.
    • 137
    Bronchopulmonary Dysplasia: Then and Now
    • 50

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 47 REFERENCES